Bright Minds Biosciences Inc.
Status: Publicly traded
Direct answer
Bright Minds Biosciences Inc. is publicly traded on NASDAQ under the ticker DRUG.
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the...
Can you invest in Bright Minds Biosciences Inc.?
Yes. Bright Minds Biosciences Inc. is publicly traded on NASDAQ under the ticker DRUG.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Bright Minds Biosciences Inc.
Detailed equity research is provided by MarketSnap.